Literature DB >> 8241524

Bis azo dyes--studies on the mechanism of complex formation with IgG modulated by heating or antigen binding.

I Roterman1, K T No, B Piekarska, J Kaszuba, R Pawlicki, J Rybarska, L Konieczny.   

Abstract

The mechanism of binding of azo dyes (bis azo) to immunoglobulin G of altered conformation, induced by heating or interaction with antigen was analysed in this work. Azo dyes: Congo Red, Evans Blue and Trypan Blue were selected for these studies. The molecules of Congo Red and Evans Blue associate readily in water and exist as polymolecular micellar species of liquid crystalline organization. Such organization of molecules appeared necessary for these dyes to interact with antibodies and to affect the formation of immune complex. It was proved by studying the properties of isomeric dyes Evans Blue and Trypan Blue, whose ability to form polymolecular conglomerates in water differs, being high for Evans Blue and low for Trypan Blue. The dyes seem to influence the formation of the immune complex generally by interacting with individual immunoglobulin molecules. The rate of exchange of dye molecules in conglomerate bound to protein varies and is the lowest for the portion of molecules which are engaged directly in the complex with protein. Electron microscopic studies also confirmed the polymolecular form of the dye in the dye-protein complex. The computational simulation of dye-dye and dye-protein interaction was performed in a model system. The micelle in the system was represented by three molecules of Congo Red. The peptide loop composed of amino acids 68-88 originating from VL IgG domain, was selected to represent protein. Amino acid side chains of this fragment were reduced to C beta. The best fitness was found for peptide chains of twisted beta conformation and independently optimized conformation of the dye in a form of "twisted ribbon" micelle. It was concluded that the IgG domains become accessible for penetration of the dye after being relaxed in the result of heating or interaction with the antigen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8241524

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  6 in total

1.  Force-field parametrization and molecular dynamics simulations of Congo red.

Authors:  Marcin Król; Tomasz Borowski; Irena Roterman; Barbara Piekarska; Barbara Stopa; Joanna Rybarska; Leszek Konieczny
Journal:  J Comput Aided Mol Des       Date:  2004-01       Impact factor: 3.686

2.  Small-molecule costimulatory blockade: organic dye inhibitors of the CD40-CD154 interaction.

Authors:  Emilio Margolles-Clark; Oliver Umland; Norma S Kenyon; Camillo Ricordi; Peter Buchwald
Journal:  J Mol Med (Berl)       Date:  2009-08-26       Impact factor: 4.599

3.  Helianthin induces antiproliferative effect on human glioblastoma cells in vitro.

Authors:  Oana Alexandru; Laura Dragutescu; Ligia Tataranu; Vasile Ciubotaru; Ani Sevastre; Ada Maria Georgescu; Oana Purcaru; Suzana Danoiu; L Magnus Bäcklund; Anica Dricu
Journal:  J Neurooncol       Date:  2010-07-16       Impact factor: 4.130

4.  Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction.

Authors:  Jinshui Chen; Yun Song; Damir Bojadzic; Alejandro Tamayo-Garcia; Ana Marie Landin; Bonnie B Blomberg; Peter Buchwald
Journal:  J Med Chem       Date:  2017-10-25       Impact factor: 7.446

Review 5.  Intramolecular immunological signal hypothesis revived--structural background of signalling revealed by using Congo Red as a specific tool.

Authors:  A Jagusiak; L Konieczny; M Krol; P Marszalek; B Piekarska; P Piwowar; I Roterman; J Rybarska; B Stopa; G Zemanek
Journal:  Mini Rev Med Chem       Date:  2015       Impact factor: 3.862

6.  The use of supramolecular structures as protein ligands.

Authors:  Barbara Stopa; Anna Jagusiak; Leszek Konieczny; Barbara Piekarska; Janina Rybarska; Grzegorz Zemanek; Marcin Król; Piotr Piwowar; Irena Roterman
Journal:  J Mol Model       Date:  2013-01-08       Impact factor: 1.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.